Disease Control in Patients With Acromegaly Switching From Injected Somatostatin Receptor Ligands to Once-Daily Oral Paltusotine: Interim Results of the PATHFNDR-1 Open-Label Extension
Related Media
Are you sure you want to reset your password?
If so, you will be redirected to the Authentication Service
